218 related articles for article (PubMed ID: 31504570)
1. Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study.
Cojutti PG; Merelli M; Bassetti M; Pea F
J Antimicrob Chemother; 2019 Dec; 74(12):3588-3595. PubMed ID: 31504570
[TBL] [Abstract][Full Text] [Related]
2. Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients.
Kawasuji H; Tsuji Y; Ogami C; Kimoto K; Ueno A; Miyajima Y; Kawago K; Sakamaki I; Yamamoto Y
BMC Pharmacol Toxicol; 2021 Mar; 22(1):13. PubMed ID: 33663616
[TBL] [Abstract][Full Text] [Related]
3. A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?
Pea F; Cojutti PG; Baraldo M
Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):303-308. PubMed ID: 28419737
[TBL] [Abstract][Full Text] [Related]
4. Initial trough concentration may be beneficial in preventing linezolid-induced thrombocytopenia.
Komatsu T; Nakamura M; Uchiyama K; Inoue G; Sakanoue K; Kawamura A; Hiratsuka K; Takayama Y; Takaso M; Atsuda K
J Chemother; 2022 Oct; 34(6):375-380. PubMed ID: 35209803
[TBL] [Abstract][Full Text] [Related]
5. High frequency of thrombocytopenia in patients with acute-on-chronic liver failure treated with linezolid.
Zhang YM; Yu W; Zhou N; Li JZ; Xu LC; Xie ZY; Lu YF; Li LJ
Hepatobiliary Pancreat Dis Int; 2015 Jun; 14(3):287-92. PubMed ID: 26063030
[TBL] [Abstract][Full Text] [Related]
6. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.
Niwa T; Suzuki A; Sakakibara S; Kasahara S; Yasuda M; Fukao A; Matsuura K; Goto C; Murakami N; Itoh Y
Clin Ther; 2009 Oct; 31(10):2126-33. PubMed ID: 19922883
[TBL] [Abstract][Full Text] [Related]
7. Reappraisal of Linezolid Dosing in Renal Impairment To Improve Safety.
Crass RL; Cojutti PG; Pai MP; Pea F
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109977
[TBL] [Abstract][Full Text] [Related]
8. The association between risk factors and time of onset for thrombocytopenia in Japanese patients receiving linezolid therapy: a retrospective analysis.
Ichie T; Suzuki D; Yasui K; Takahashi H; Matsuda M; Hayashi H; Sugiura Y; Sugiyama T
J Clin Pharm Ther; 2015 Jun; 40(3):279-84. PubMed ID: 25732525
[TBL] [Abstract][Full Text] [Related]
9. Thrombocytopenia Associated with Linezolid Therapy in Solid Organ Transplant Recipients: A Retrospective Cohort Study.
Tessier JM; Puzio T; Young A; Wolfe L; Han J; Duane TM
Surg Infect (Larchmt); 2015 Aug; 16(4):361-7. PubMed ID: 26207396
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy and safety of vancomycin compared with linezolid for the treatment of neonatal gram-positive bacterial sepsis].
Tang L; Fang J; Wang SN; Weng XH; Li JJ; Shang EN
Zhonghua Er Ke Za Zhi; 2016 Sep; 54(9):686-91. PubMed ID: 27596084
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug management of linezolid: a missed opportunity for clinicians?
Cattaneo D; Gervasoni C; Cozzi V; Castoldi S; Baldelli S; Clementi E
Int J Antimicrob Agents; 2016 Dec; 48(6):728-731. PubMed ID: 27769709
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients.
Dong HY; Xie J; Chen LH; Wang TT; Zhao YR; Dong YL
Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):1029-35. PubMed ID: 24515096
[TBL] [Abstract][Full Text] [Related]
13. High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.
Nukui Y; Hatakeyama S; Okamoto K; Yamamoto T; Hisaka A; Suzuki H; Yata N; Yotsuyanagi H; Moriya K
J Antimicrob Chemother; 2013 Sep; 68(9):2128-33. PubMed ID: 23625638
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for linezolid-induced thrombocytopenia in patients without haemato-oncologic diseases.
Choi GW; Lee JY; Chang MJ; Kim YK; Cho Y; Yu YM; Lee E
Basic Clin Pharmacol Toxicol; 2019 Feb; 124(2):228-234. PubMed ID: 30171804
[TBL] [Abstract][Full Text] [Related]
15. Linezolid-induced thrombocytopenia increases mortality risk in intensive care unit patients, a 10 year retrospective study.
Kim HS; Lee E; Cho YJ; Lee YJ; Rhie SJ
J Clin Pharm Ther; 2019 Feb; 44(1):84-90. PubMed ID: 30243033
[TBL] [Abstract][Full Text] [Related]
16. Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 days.
Sato Y; Iguchi M; Kato Y; Morioka H; Hirabayashi A; Tetsuka N; Tomita Y; Kato D; Yamada K; Kimura H; Yagi T
Nagoya J Med Sci; 2020 Aug; 82(3):407-414. PubMed ID: 33132425
[TBL] [Abstract][Full Text] [Related]
17. Impact of high plasma concentrations of linezolid in Taiwanese adult patients- therapeutic drug monitoring in improving adverse drug reactions.
Cheng CN; Wu CC; Kuo CH; Wang CC; Wang JT; Lin YT; Jhang RS; Lin SW
J Formos Med Assoc; 2021 Jan; 120(1 Pt 2):466-475. PubMed ID: 32600864
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for linezolid-associated thrombocytopenia and negative effect of carbapenem combination.
Kaya Kılıç E; Bulut C; Sönmezer MÇ; Ozel Ö; Ataman Hatipoğlu Ç; Tuncer Ertem G; Tülek N; Kınıklı S
J Infect Dev Ctries; 2019 Oct; 13(10):886-891. PubMed ID: 32084018
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients.
Pea F; Viale P; Cojutti P; Del Pin B; Zamparini E; Furlanut M
J Antimicrob Chemother; 2012 Aug; 67(8):2034-42. PubMed ID: 22553142
[TBL] [Abstract][Full Text] [Related]
20. Does the conventional dosage of linezolid necessitate therapeutic drug monitoring?-Experience from a prospective observational study.
Fang J; Chen C; Wu Y; Zhang M; Zhang Y; Shi G; Yao Y; Chen H; Bian X
Ann Transl Med; 2020 Apr; 8(7):493. PubMed ID: 32395537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
